Skip to main content

Advertisement

Fig. 1 | Cancer Communications

Fig. 1

From: Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations

Fig. 1

Kaplan-Meier curves of the progression-free survival (PFS) and overall survival (OS) for NSCLC patients with EGFR signaling pathway alterations. PFS (a) and OS (b) were analyzed in the 416 NSCLC patients, according to the EGFR signaling pathway alterations. In the 156 NSCLC patients with EGFR mutation, PFS (c) and OS (d) were analyzed according to the EGFR signaling pathway alterations. The survival rates were compared using the log-rank test. NSCLC non-small cell lung cancer, PFS progression-free survival, OS overall survival

Back to article page